DR LAL PATHLABS Financial Statement Analysis
|
||
|
The Revenues of DR LAL PATHLABS have increased by 10.40% YoY .
The Earnings Per Share (EPS) of DR LAL PATHLABS has increased by 36.01 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
DR LAL PATHLABS Last 5 Annual Financial Results
[BOM: 539524|NSE : LALPATHLAB]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Operating Income | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr | ₹1,330 Cr |
| Expenses | ₹1,617 Cr | ₹1,527 Cr | ₹1,527 Cr | ₹1,145 Cr | ₹987 Cr |
| Operating Profit (Excl OI) | ₹609 Cr | ₹490 Cr | ₹561 Cr | ₹436 Cr | ₹344 Cr |
| Other Income | ₹69 Cr | ₹42 Cr | ₹53 Cr | ₹51 Cr | ₹55 Cr |
| Interest | ₹29 Cr | ₹38 Cr | ₹30 Cr | ₹16 Cr | ₹15 Cr |
| Depreciation | ₹144 Cr | ₹150 Cr | ₹108 Cr | ₹77 Cr | ₹73 Cr |
| Profit Before Tax | ₹505 Cr | ₹344 Cr | ₹475 Cr | ₹394 Cr | ₹311 Cr |
| Profit After Tax | ₹362 Cr | ₹241 Cr | ₹350 Cr | ₹296 Cr | ₹228 Cr |
| Consolidated Net Profit | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr | ₹226 Cr |
| Earnings Per Share (Rs) | ₹58.28 | ₹42.85 | ₹28.65 | ₹41.37 | ₹34.99 |
| PAT Margin (%) | 20.00 | 16.27 | 11.95 | 16.78 | 18.75 |
| ROE(%) | 25.15 | 21.27 | 15.80 | 26.45 | 26.89 |
| ROCE(%) | 31.53 | 27.89 | 20.34 | 32.67 | 36.03 |
| Total Debt/Equity(x) | 0.00 | 0.05 | 0.15 | 0.24 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 27,248.8 Cr |
| Revenue (TTM) | : | ₹ 2,599.7 Cr |
| Net Profit(TTM) | : | ₹ 539.8 Cr |
| EPS (TTM) | : | ₹ 64.4 |
| P/E (TTM) | : | 50.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| DR LAL PATHLABS | 5.3% | 2.7% | 2.6% |
| MAX HEALTHCARE INSTITUTE | -2.8% | 3.1% | 15.3% |
| APOLLO HOSPITALS ENTERPRISE | -0.7% | 5.1% | 10% |
| FORTIS HEALTHCARE | -2.6% | 4.1% | 70.1% |
| GLOBAL HEALTH | -5.9% | -2.3% | 22.8% |
| NARAYANA HRUDAYALAYA | 0.6% | 3% | 42.3% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 0.6% | 5.7% | 36.9% |
| ASTER DM HEALTHCARE | -3% | 7.6% | 57.4% |
| RAINBOW CHILDRENS MEDICARE | -0.1% | 2.2% | -6.7% |
DR LAL PATHLABS Revenues
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 10.40 % |
| 5 Yr CAGR | 13.74 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,227 Cr | 10.40 | |
| Mar2024 | ₹2,017 Cr | -3.38 | |
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | 18.86 | |
| Mar2021 | ₹1,330 Cr | - | |
DR LAL PATHLABS Operating Profit
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 24.38 % |
| 5 Yr CAGR | 15.40 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹609 Cr | 24.38 | |
| Mar2024 | ₹490 Cr | -12.64 | |
| Mar2023 | ₹561 Cr | 28.52 | |
| Mar2022 | ₹436 Cr | 26.98 | |
| Mar2021 | ₹344 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 12.64 % |
| 5 Yr CAGR | 1.45 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 27.36% | 12.64 | |
| Mar2024 | 24.29% | -9.57 | |
| Mar2023 | 26.86% | -2.65 | |
| Mar2022 | 27.59% | 6.81 | |
| Mar2021 | 25.83% | - | |
DR LAL PATHLABS Profit After Tax
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 49.78 % |
| 5 Yr CAGR | 12.17 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | 29.07 | |
| Mar2021 | ₹226 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 22.93 % |
| 5 Yr CAGR | 1.63 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 20 % | 22.93 | |
| Mar2024 | 16.27 % | 36.15 | |
| Mar2023 | 11.95 % | -28.78 | |
| Mar2022 | 16.78 % | -10.51 | |
| Mar2021 | 18.75 % | - | |
DR LAL PATHLABS Earnings Per Share (EPS)
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 36.01 % |
| 5 Yr CAGR | 13.60 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹58 | 36.01 | |
| Mar2024 | ₹43 | 49.56 | |
| Mar2023 | ₹29 | -30.75 | |
| Mar2022 | ₹41 | 18.23 | |
| Mar2021 | ₹35 | - | |
DR LAL PATHLABS Return on Capital Employed (ROCE)
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 13.05 % |
| 5 Yr CAGR | -3.28 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 31.53% | 13.05 | |
| Mar2024 | 27.89% | 37.12 | |
| Mar2023 | 20.34% | -37.74 | |
| Mar2022 | 32.67% | -9.33 | |
| Mar2021 | 36.03% | - | |
DR LAL PATHLABS Share Price vs Sensex
| Current Share Price | : | ₹3,251.7 |
| Current MarketCap | : | ₹ 27,248.8 Cr |
| Updated EOD on | : | Nov 03,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 5.3% |
2.7% |
2.6% |
| SENSEX | -0.9% |
4.6% |
5% |
DR LAL PATHLABS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE SMALLCAP | 0.9% | 4% | 2.5% |
| BSE 250 SMALLCAP INDEX | 0.7% | 4.2% | 0.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MIDSMALL HEALTHCARE | 1.6% | 3.6% | 6.8% |
| NIFTY SMALLCAP 50 | 0.7% | 6.4% | 2.4% |
| NIFTY MIDSMALLCAP 400 | 0.7% | 5.2% | 5.3% |
| NIFTY 500 EQUAL WEIGHT | 0.6% | 4% | 4.6% |
| NIFTY SMALLCAP 250 | 0.6% | 4.5% | 1.7% |
You may also like the below Video Courses
FAQ about DR LAL PATHLABS Financials
How the annual revenues of DR LAL PATHLABS have changed ?
The Revenues of DR LAL PATHLABS have increased by 10.40% YoY .
How the Earnings per Share (EPS) of DR LAL PATHLABS have changed?
The Earnings Per Share (EPS) of DR LAL PATHLABS has increased by 36.01 % YoY .
Check out Intrinsic Value of Peers of DR LAL PATHLABS
Compare Stock Analytics of Peers of DR LAL PATHLABS
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs
